Neuromed- Integrated Health Life Platform and Biobank (PLATONE)
Sponsor: Neuromed IRCCS
A observational or N/A phase clinical study on Cancer and Cardiovascular Diseases, this trial is completed. The trial is conducted by Neuromed IRCCS and has accumulated 14 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2023 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Feb 2022 — Dec 2023 [monthly]
Recruiting
-
Dec 2021 — Feb 2022 [monthly]
Recruiting
▶ Show 9 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2020 — Dec 2020 [monthly]
Recruiting
-
Jun 2019 — Nov 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Oct 2018 — Jun 2019 [monthly]
Not Yet Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Not Yet Recruiting
-
May 2018 — Jun 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — May 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Neuromed IRCCS
For direct contact, visit the study record on ClinicalTrials.gov .